| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0dbec044b99ad963cf39a7e519e444a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b65d454a932976fa2078481424563b4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fba5958f057911361a95163920d75938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_029116ee41eeec8a03f88a8cddbaa758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59b30da8f445eaa0e0148f7a5312d95b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00 |
| filingDate |
2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e01c8e02af86bd1a89792e98ba03130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a64a3fd475ce1aea1fd707091c537720
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30c4ffa76a9905b3f47b8e8acc30f1e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2dde47101fa1be520fd80ef8797cce4 |
| publicationDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012010589-A1 |
| titleOfInvention |
Local delivery of therapeutic agent to heart valves |
| abstract |
The present invention relates to implantable medical devices and methods that employ these medical devices to treat heart valves. In one embodiment, a medical device is provided comprising a body. The body may have a portion thereof including therapeutic agent and can be configured to support the device proximate a heart valve. Methods in accordance with embodiments of the present invention may also include providing a medical device having a body with at least a portion thereof including a therapeutic agent. These methods may also include positioning the medical device in a location proximate to a downstream surface of the heart valve and securing the device. The therapeutic agent released may then be delivered to the heart valve. |
| priorityDate |
2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |